Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | BRCA1 | P38398 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.69 |
| ▸ | F2 | P00734 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexamidine SCHEMBL985947 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Hexamidine SCHEMBL128384 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Pentamidine SCHEMBL27719324 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Pentamidine SCHEMBL19462606 | 0.99 | ALDH1A1 (0.97) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Pentamidine SCHEMBL5014184 | 0.99 | ALDH1A1 (0.97) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Pentamidine SCHEMBL2658011 | 0.97 | ALDH1A1 (0.95) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Pentamidine SCHEMBL23063972 | 0.96 | ALDH1A1 (0.92) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Propamidine SCHEMBL293021 | 0.96 | ALDH1A1 (0.92) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Pentamidine SCHEMBL16050177 | 0.94 | ALDH1A1 (0.88) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 | |
| Pentamidine SCHEMBL18007221 | 0.94 | ALDH1A1 (0.88) | ALDH1A1LMNAPOLBRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4293 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4631514-A1 | ORAL POLYPEPTIDE COMPOSITION AND USE THEREOF | Hefei Tianhui Biotech Co., Ltd. (CN) | 2025-10-15 | — | — | EP | claimed |
| US-20250281579-A1 | Methods and Compositions for Oral Administration of Proteins | ORAMED PHARMACEUTICALS INC (IL) | 2025-09-11 | — | — | US | claimed |
| EP-3976197-B1 | THERAPEUTICS AND METHODS FOR PREDICTING AND OVERCOMING ENDOCRINE RESISTANCE IN BREAST CANCER | LUNELLA BIOTECH INC (CA) | 2025-07-16 | — | — | EP | claimed |
| WO-2025111413-A1 | TREATMENT FOR SKIN DISORDERS | Mycotechnology, Inc. (US) | 2025-05-30 | — | — | WO | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| CN-119742019-A | Method for relieving noise nerve injury and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2025-04-01 | — | — | CN | claimed |
| CN-111183360-B | Biomarker combinations for simultaneous assessment of non-alcoholic steatohepatitis and liver fibrosis status | 生物辐射欧洲有限公司 | 2024-10-18 | — | — | CN | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| CN-116080114-B | Preparation method of biaxially oriented PDCPD film | 四川东方绝缘材料股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| WO-1991015201-A1 | METHOD OF TREATING DISEASES ASSOCIATED WITH ELEVATED LEVELS OF INTERLEUKIN 1 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1991-10-17 | — | — | WO | claimed |
| EP-0345926-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING PENTAMIDINE | FISONS CORPORATION (US) | 1991-08-07 | — | — | EP | claimed |
| EP-0364559-A4 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | — | 1991-01-09 | — | — | EP | claimed |
| EP-0364559-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS. | SCRIPPS CLINIC RES (US) | 1990-04-25 | — | — | EP | claimed |
| EP-0345926-A1 | Pharmaceutical compositions containing pentamidine | FISONS CORPORATION (US) | 1989-12-13 | — | — | EP | claimed |
| WO-1989008658-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-09-21 | — | — | WO | claimed |
| US-4853416-A | TREATING PNEUMO-CYSTIS CARINII PNEUMONIA; AIDS; | FISONS CORPORATION (GB) | 1989-08-01 | — | — | US | claimed |
| EP-0315467-A2 | Pentamidine salts useful in the treatment and prophylaxis of pneumocystis carinii pneumonia | LyphoMed, Inc. (US) | 1989-05-10 | — | — | EP | claimed |
| US-4823784-A | Aerosol inhalation apparatus | CADEMA MEDICAL PRODUCTS, INC. (US) | 1989-04-25 | — | — | US | claimed |
| EP-0292100-A1 | Composition for the prophylaxis or treatment of pneumocystis carinii pneumonia | Sloan-Kettering Institute For Cancer Research (US) | 1988-11-23 | — | — | EP | claimed |